MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent ...

Texas has the second-highest population of LGBTQ people in the country, with 1.1 million of its residents identifying at ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

VIR-5818 is under clinical development by Vir Biotechnology and currently in Phase II for Metastatic Breast Cancer.

Average was an advocate for people living with HIV and terminal illnesses, as well as marriage equality and LGBTQ+ rights.

Various animal species suffer from STIs similar to humans, such as syphilis in rabbits and HIV-like viruses in chimps and ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

Matthew Kavanagh, the director of Georgetown University's Centre for Global Health Policy & Politics and an advisor to the United Nations explains on the progress and challenges in the ...

HIV/AIDS cases and deaths have gone up dramatically in the Philippines in the last decade, even though there are drugs to ...

Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility.